Press Releases

Accuray and RaySearch Announce Second Long-Term Collaboration Agreement SUNNYVALE, Calif., and STOCKHOLM, Sweden October 5, 2015 -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today that they have expanded on their existing relationship with the signing of a new long-term collaboration agreement which will lead to the integration of treatment planning support for the TomoTherapy® and CyberKnife® Systems in the RayStation® treatment planning system (TPS). RayStation is one of the most advanced independent treatment planning systems available and will provide an ideal complement to the unique Accuray treatment delivery systems, enabling customers to choose the delivery technology that will best meet their needs. Accuray and RaySearch previously announced a long-term collaboration regarding the RayCare® oncology information system. Read More »
Kevin Waters Named Chief Financial Officer Of Accuray SUNNYVALE, Calif., Sept. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kevin Waters, formerly Senior Vice President, Finance, has been promoted to Chief Financial Officer of the Company effective as of today. He succeeds Gregory E. Lichtwardt who retired as Executive Vice President, Operations, and Chief Financial Officer of the Company effective as of September 14, 2015. Mr. Lichtwardt will continue in a consulting role with the Company for an interim period. Read More »
Accuray to Participate in the Morgan Stanley Global Healthcare Conference 2015 SUNNYVALE, Calif., September 1, 2015-- Accuray Incorporated (Nasdaq: ARAY), announced today that its management team is scheduled to present at the Morgan Stanley Global Healthcare Conference 2015 in New York, NY on Thursday, September 17, 2015 at 12:55pm ET. Read More »
Accuray Awarded Multi-System Order by 21st Century Oncology SUNNYVALE, Calif., August 21, 2015 -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received a multi-system order from 21st Century Oncology for one CyberKnife® M6™ and four TomoHDA™ Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are used worldwide to provide extremely precise radiation treatments for cancerous and non-cancerous tumors throughout the body. The TomoTherapy Systems will replace conventional linear accelerators in single vault freestanding centers, reinforcing the TomoTherapy’s value as a mainstream radiation therapy device. Accuray booked the order in its first fiscal quarter of 2016. Read More »
Accuray Generates 14% Year-Over-Year Gross Order Growth During Fourth Quarter SUNNYVALE, Calif., August 20, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the fiscal fourth quarter and fiscal year ended June 30, 2015. Read More »
Accuray To Report Fiscal 2015 Fourth Quarter and Full Year Financial Results On August 20, 2015 SUNNYVALE, CA., August 3, 2015 -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2015 on August 20, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »
Accuray Products Received Highest Composite User Satisfaction Ratings in Latest MD Buyline Report SUNNYVALE, Calif., July 27, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2015 MD Buyline Market Intelligence Briefing™. The most recent ratings trend also shows Accuray has achieved the highest ratings among industry peers over the past two years. Read More »
New TomoTherapy® System Data Presented at Leading Scientific Industry Meeting SUNNYVALE, Calif., July 14, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that studies on the clinical use of the TomoTherapy® System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Anaheim, California July 12 – July 16, 2015. Read More »